# Mixed Schedule Study of Live Oral Rotavirus Vaccines and Trivalent P2-VP8 Subunit Rotavirus Vaccine

> **NCT04344054** · PHASE2 · COMPLETED · sponsor: **PATH** · enrollment: 850 (actual)

## Conditions studied

- Rotavirus Vaccine

## Interventions

- **BIOLOGICAL:** RV3-BB
- **BIOLOGICAL:** Trivalent P2-VP8
- **BIOLOGICAL:** Rotarix
- **BIOLOGICAL:** RV3-BB birth dose
- **BIOLOGICAL:** Trivalent P2-VP8 Booster dose

## Key facts

- **NCT ID:** NCT04344054
- **Lead sponsor:** PATH
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-22
- **Primary completion:** 2022-09-06
- **Final completion:** 2022-09-09
- **Target enrollment:** 850 (ACTUAL)
- **Last updated:** 2022-11-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04344054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04344054, "Mixed Schedule Study of Live Oral Rotavirus Vaccines and Trivalent P2-VP8 Subunit Rotavirus Vaccine". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04344054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*